Qiming Ventures Sees More U.S. Entrepreneurs in China

The video discusses the impact of US-China tensions on healthcare innovation, highlighting a significant drop in Chinese investments in the US. Entrepreneurs are moving to China due to cheaper clinical development costs and the ability to license technology globally. Despite being behind in biotech, China shows promise in medical devices. Trade tensions have led to lower investment valuations, benefiting VC funds. AI investment continues in China, with a focus on ethical due diligence. The WeWork saga has affected market valuations, reflecting broader investment trends.

What are the implications of the growing trade tensions between the US and China on healthcare innovation in China?

How has the funding from Chinese companies and funds looking to invest in the US changed in the last 18 months?

What factors are leading entrepreneurs from the US to move to China to start companies?

In what ways has the investment in healthcare technology in China changed recently?

What are the challenges faced by entrepreneurs when starting companies in the US compared to China?

How do you assess the impact of the US blacklist on AI companies in China?

What are the ethical considerations investors must take into account when investing in China?